Cullinan Oncology, Inc(NASDAQ:CGEM) 
Cullinan Management, Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalati...
Website: https://www.cullinanoncology.com/
Founded: 2016
CEO: Owen Hughes
Sector: Pharmaceuticals
Industry:
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 7.28
H 7.62
L 7.11
C 7.41
V 600,301
10EMA 7.41
20EMA 7.41
60EMA 7.41
120EMA 7.41
250EMA 7.41